| Literature DB >> 34748577 |
Ines Friedrich1, Bernhard Bodenberger1, Hannes Neubauer1, Robert Hertel1,2, Rolf Daniel1.
Abstract
Serratia marcescens is a species that belongs to the family of Yersiniaceae. This family comprises taxa representing opportunistic human- and phytopathogens but also plant growth-promoting rhizobacteria (PGPR). This study describes a novel Gram-negative strain (LVF3R) of the species Serratia marcescens. The strain was characterized genomically, morphologically, and physiologically. In addition, the potential of the isolate to act as a host strain to assess the diversity of Serratia associated phages in environmental samples was explored. Average nucleotide identity analysis revealed that LVF3R belongs to the species Serratia marcescens. In silico analysis and ProphageSeq data resulted in the identification of one prophage, which is capable of viral particle formation. Electron microscopy showed cells of a rod-shaped, flagellated morphotype. The cells revealed a length and width of 1-1.6 μm and 0.8 μm, respectively. LVF3R showed optimal growth at 30 C and in the presence of up to 2% (w/v) NaCl. It exhibited resistances to ampicillin, erythromycin, oxacillin, oxytetracycline, rifampicin, tetracycline, and vancomycin. Genome data indicate that strain S. marcescens LVF3R is a potential PGPR strain. It harbors genes coding for indole acetic acid (IAA) biosynthesis, siderophore production, plant polymer degradation enzymes, acetoin synthesis, flagellar proteins, type IV secretion system, chemotaxis, phosphorous solubilization, and biofilm formation.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34748577 PMCID: PMC8575298 DOI: 10.1371/journal.pone.0259673
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Transmission electron microscopy images of LVF3R.
The micrograph (A) shows the typically observed cell morphotypes of S. marcescens strain LVF3R. Micrograph (B) shows S. marcescens LVF3R surrounded by its active prophages. Cells were grown for 24 h at 30°C in TSB-10 medium, negatively stained and used for TEM analysis.
Fig 2S. marcescens LVF3R growth properties.
(A) Growth of LVF3R in 4 mLTSB medium with different salt concentrations after 3 h incubation at 180 rpm and 30°C. (B) LVF3R growth in TSB-10 medium at different temperatures after 3 h incubation at 180 rpm. (C) Growth analysis of LVF3R at the optimum temperature (30°C) in 25 mL TSB-10 medium. Measurements were performed in triplicate. The standard deviation in (A) and (B) is shown as error bars. In (C) different shades of purple indicate each replicate.
Phenotypic characteristics of strain LVF3R and phylogenetically related species Serratia sp. S119R, S marcescens ATCC 13880T, S. marcescens DSM 17174R, S. nematodiphila DSM 21420T.
| Characteristics | |||||
|---|---|---|---|---|---|
|
|
| Peanut nodule | Pond water | Activated sludge | Intestine of nematode |
|
| – | – | – | + | – |
|
| – | – | + | + | + |
|
| + | + | + | + | + |
|
| + | n/a | n/a | n/a | n/a |
|
| + | n/a | n/a | + | n/a |
|
| |||||
| Range | 10–45 | n/a | n/a | n/a | 4–42 |
| Optimum | 30 | 28 | 30–37 | 28–37 | 33.5 |
|
| |||||
| Range | 0–60 | n/a | n/a | 0–70 | 20–70 |
| Optimum | 0–20 | 10 | 5 | 5 | 45 |
|
| |||||
| 2-nitrophenyl-βD-galactopyranoside | + | + | + | n/a | n/a |
| L-arginine | – | – | – | + | + |
| L-lysine | + | + | + | + | + |
| L-ornithine | + | + | + | + | + |
| Trisodium citrate | + | + | + | + | + |
| Sodium thiosulfate | – | – | – | – | – |
| Urea | + | – | – | – | – |
| L-tryptophane | – | – | – | + | + |
| L-tryptophane (indole production) | – | – | v | – | – |
| Sodium pyruvate (Voges Proskauer) | + | – | v | + | + |
| Gelatin | + | + | + | n/a | + |
| D-glucose | + | + | + | + | + |
| D-mannitol | + | + | + | n/a | + |
| Inositol | + | + | v | n/a | n/a |
| D-sorbitol | + | + | + | + | + |
| L-rhamnose | + | – | v | n/a | n/a |
| D-sucrose | + | + | + | + | + |
| D-melibiose | + | + | + | – | + |
| Amygdalin | + | + | + | n/a | n/a |
| L-arabinose | – | + | v | – | + |
|
| + | n/a | n/a | + | + |
|
| – | – | – | – | – |
|
| |||||
| Ampicillin | + | n/a | – | – | – |
| Chloramphenicol | – | + | + | – | – |
| Doxycycline | – | n/a | + | n/a | n/a |
| Erythromycin | + | n/a | + | + | n/a |
| Kanamycin | – | n/a | + | – | – |
| Meropenem | – | n/a | n/a | n/a | – |
| Oxacillin | + | n/a | – | n/a | n/a |
| Oxytetracycline | + | n/a | n/a | n/a | n/a |
| Rifampicin | + | n/a | n/a | n/a | – |
| Tetracycline | + | n/a | + | + | – |
| Streptomycin | – | n/a | n/a | – | – |
| Vancomycin | + | n/a | – | n/a | + |
|
| 59.29 | 59.85 | 59.8 | 58 | 59.52 |
In bold: Sorted by categories.
Taxa: 1, strain S. marcescens LVF3R; 2, Serratia sp. S119R (data from [55]); 3, S. marcescens ATCC 13880T (data from BacDive [56] on 24 February 2021); 4, S. marcescens subsp. sakuensis KCTC 42172T (data from [6,57]; LPSN [58] accessed on 24 February 2021); 5, S. nematodiphila DSM 21420T (data from [57]; BacDive [56] accessed on 24 February 2021); +, Positive; -, negative; v, some strains showed activity; n/a, not available.
Genome statistics of the LVF3R chromosome and p87710 plasmid.
| Features | Chromosome | Plasmid |
|---|---|---|
| Genome size (bp) | 5,440,698 | 87,710 |
| GC content (%) | 59.29 | 53.27 |
| Coverage | 285.9-fold | 418.7-fold |
| CDS | 5,159 | 94 |
| rRNA genes | 129 | 0 |
| tRNA genes | 92 | 0 |
| ncRNA | 15 | 0 |
| CRISPR | 0 | 0 |
| Prophage(s) | 2 | 0 |
Fig 3Genome-based phylogenetic analysis of Serratia marcescens LVF3R.
All genomes from available type strains (T) included in the TYGS database [36] and a representative strain (R) from the genus Serratia were examined. Calculations were done with pyani [37,68] using ANIm method with default parameters. LVF3R is depicted in bold red.
Fig 4Read coverage profile of sequenced LVF3R prophages, mapped onto its corresponding host genome.
The blue arrows depict the prophage regions predicted by PHASTER [41]. Green arrows indicate the experimentally verified prophage region. The image displays the read coverage of the genome between base 2,022,912 to 2,5011,011 (478,099 kb).
Fig 5Host strain LVF3 challenged with metaviral sample.
Different plaque morphologies can be observed.